Contact this trialFirst, we need to learn more about you.
NMDA Receptor Antagonist
Ketamine for PTSD and Depression
Recruiting0 awardsPhase 1
Minneapolis, Minnesota
This trial is testing whether ketamine can help reduce symptoms of PTSD and MDD in veterans who have not responded to other treatments. The study will also look at the mechanisms underlying comorbid PTSD and MDD.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.